6,625 reports of this reaction
2.6% of all MYCOPHENOLATE MOFETIL HYDROCHLORIDE reports
#4 most reported adverse reaction
DIARRHOEA is the #4 most commonly reported adverse reaction for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, manufactured by Genentech, Inc.. There are 6,625 FDA adverse event reports linking MYCOPHENOLATE MOFETIL HYDROCHLORIDE to DIARRHOEA. This represents approximately 2.6% of all 257,534 adverse event reports for this drug.
MYCOPHENOLATE MOFETIL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for MYCOPHENOLATE MOFETIL HYDROCHLORIDE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 6,625 FDA reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 2.6% of all adverse event reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, making it a notable side effect.
If you experience diarrhoea while taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.